Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03954704
Title Study of GS-1423 in Participants With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Gilead Sciences
Indications

gastric adenocarcinoma

gastroesophageal junction adenocarcinoma

Advanced Solid Tumor

Therapies

Fluorouracil + GS-1423 + Leucovorin + Oxaliplatin

GS-1423

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Scottsdale Healthcare Hospitals d/b/a HonorHealth Scottsdale Arizona 85258 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
NEXT Oncology San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field